Cover Image

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)

Show other versions (1)

Riociguat is a soluble guanylate cyclase stimulator approved for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTPEH). The objective of this study was to evaluate right heart size and function assessed by echocardiography during long term treatment with rio...

Full description

Saved in:
Bibliographic Details
Main Authors: Marra, Alberto M. (Author) , Benjamin, Nicola (Author) , Eichstaedt, Christina (Author) , Egenlauf, Benjamin (Author) , Harutyunova, Satenik (Author) , Fischer, Christine (Author) , Grünig, Ekkehard (Author)
Format: Article (Journal)
Language:English
Published: 19 December 2018
In: Respiratory research
Year: 2018, Volume: 19
ISSN:1465-993X
DOI:10.1186/s12931-018-0957-y
Online Access:Verlag, Volltext: https://doi.org/10.1186/s12931-018-0957-y
Get full text
Author Notes:Alberto M. Marra, Michael Halank, Nicola Benjamin, Eduardo Bossone, Antonio Cittadini, Christina A. Eichstaedt, Benjamin Egenlauf, Satenik Harutyunova, Christine Fischer, Henning Gall, Hossein Ardeschir Ghofrani, Marius M. Hoeper, Tobias J. Lange, Karen M. Olsson, Hans Klose and Ekkehard Grünig
Search Result 1
Cover Image

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study) by Marra, Alberto M. (Author) , Benjamin, Nicola (Author) , Eichstaedt, Christina (Author) , Egenlauf, Benjamin (Author) , Harutyunova, Satenik (Author) , Fischer, Christine (Author) , Grünig, Ekkehard (Author) ,

BioMed Central 19 December 2018 Universitätsbibliothek Heidelberg 19 December 2018

Get full text
Article (Journal) Book/Monograph Online Resource

Saved in:
Show all versions (2)

Similar Items